New study in Nature Communications uses Salipro for investigating neurological drugs

Salipro® technology paves the way for developing safer drugs to treat anxiety, sleep disorders and epilepsy. Congratulations to Hibbs and co-workers for the structures of the Salipro-GABAA receptor in complex with zolpidem and DMCM!

Publication reference:
S. Zhu, et al., Structural and dynamic mechanisms of GABAAreceptor modulators with opposing activities. Nat. Commun. 13, 4582 (2022).